Science Explorer Back to mapMap

Most cited papers from Guangdong Medical College

What are the most cited papers from Guangdong Medical College?

The most cited paper from Guangdong Medical College is "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (Daniel J. Klionsky et al., 2021), with 2,743 citations. Next come "mTOR is a key modulator of ageing and age-related disease" (1,729) and "Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)" (1,473).

Showing 50 of 60 papers. Every paper with more than 328 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
2 mTOR is a key modulator of ageing and age-related disease Simon C. Johnson, Peter S. Rabinovitch, Matt R. Kaeberlein · Nature Open access 15 Jan 2013 1,729
3 Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) Fang Jiang, Liehua Deng, Liangqing Zhang et al. · Journal of General Internal Medicine Open access 4 Mar 2020 1,473
4 Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Shaoqing Lei, Fang Jiang, Wating Su et al. · EClinicalMedicine Open access Apr 2020 1,455
5 Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis Yuli Huang, Xiaoyan Cai, Weiyi Mai et al. · BMJ ReviewOpen access 23 Nov 2016 1,049
6 Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics Dongbin Yang, Weihong Zhang, Huanyun Zhang et al. · Theranostics Open access 2020 1,036
7 METTL3-mediated m 6 A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance Qiang Wang, Chen Chen, Qingqing Ding et al. · Gut 3 Oct 2019 973
8 mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges Zhilin Zou, Tao Tao, Hongmei Li et al. · Cell & Bioscience Open access 10 Mar 2020 959
9 p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation Wei Jing Liu, Lin Ye, Wei Huang et al. · Cellular & Molecular Biology Letters Open access Dec 2016 953
10 Cancer Cell Membrane–Biomimetic Nanoparticles for Homologous-Targeting Dual-Modal Imaging and Photothermal Therapy Ze Chen, Pengfei Zhao, Zhenyu Luo et al. · ACS Nano 7 Nov 2016 910
11 The Structure-Activity Relationship of the Antioxidant Peptides from Natural Proteins Tangbin Zou, Taiping He, Hua‐Bin Li et al. · Molecules Open access 12 Jan 2016 880
12 The Gut Microbiota and Alzheimer’s Disease Chunmei Jiang, Guangning Li, Pengru Huang et al. · Journal of Alzheimer s Disease 31 Mar 2017 862
13 Nanomedicine in cancer therapy Dahua Fan, Yongkai Cao, Meiqun Cao et al. · Signal Transduction and Targeted Therapy Open access 6 Aug 2023 857
14 PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Yan Peng, Yuanyuan Wang, Cheng Zhou et al. · Frontiers in Oncology Open access 24 Mar 2022 806
15 Single-Step Assembly of DOX/ICG Loaded Lipid–Polymer Nanoparticles for Highly Effective Chemo-photothermal Combination Therapy Mingbin Zheng, Caixia Yue, Yifan Ma et al. · ACS Nano 15 Feb 2013 804
16 Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Simon I Hay et al. · The Lancet Open access2,780 authors Oct 2025 762
17 Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis Xiaoyan Cai, Yunlong Zhang, Meijun Li et al. · BMJ Open access 15 Jul 2020 754
18 Cancer immunotherapy: Pros, cons and beyond Shuzhen Tan, Dongpei Li, Xiao Ming Zhu · Biomedicine & Pharmacotherapy Open access 18 Jan 2020 698
19 Automatic Tuberculosis Screening Using Chest Radiographs Stefan Jaeger, Alexandros Karargyris, Sema Candemir et al. · IEEE Transactions on Medical Imaging Open access Oct 2013 685
20 RNA sequencing: new technologies and applications in cancer research Mingye Hong, Shuang Tao, Ling Zhang et al. · Journal of Hematology & Oncology Open access Dec 2020 630
21 Replicative and Chronological Aging in Saccharomyces cerevisiae Valter Daniel Longo, Gerald S. Shadel, Matt R. Kaeberlein et al. · Cell Metabolism Open access Jul 2012 626
22 A Regulatory Signaling Loop Comprising the PGAM5 Phosphatase and CK2 Controls Receptor-Mediated Mitophagy Guo Chen, Zhe Han, Du Feng et al. · Molecular Cell Open access 17 Apr 2014 597
23 ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy Wenxian Wu, Weili Tian, Zhe Hu et al. · EMBO Reports Open access 26 Mar 2014 595
24 Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial Zixian Wang et al. · Cancer Cell Open access Mar 2022 592
25 The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer Wei-Cheng Liang, Wei-ming Fu, Cheuk-Wa Wong et al. · Oncotarget Open access 5 Jun 2015 587
26 Microsatellite instability: a review of what the oncologist should know Kai Li, Haiqing Luo, Haiqing Luo et al. · Cancer Cell International Open access 13 Jan 2020 542
27 Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy Jumin Huang et al. · Gut Open access 18 May 2021 535
28 Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma Bin Zhang, Jie Tian, Di Dong et al. · Clinical Cancer Research 9 Mar 2017 534
29 Selective autophagy of intracellular organelles: Recent research advances Wen Li et al. · Theranostics Open access 9 Oct 2020 510
30 Recent developments in luminescent coordination polymers: Designing strategies, sensing application and theoretical evidences Jian-Qiang Liu, Zhidong Luo, Ying H. Pan et al. · Coordination Chemistry Reviews 18 Dec 2019 504
31 Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Mohsen Naghavi et al. · The Lancet Open access2,463 authors Oct 2025 500
32 Signaling pathways in rheumatoid arthritis: implications for targeted therapy Qian Ding, Wei Hu, Ran Wang et al. · Signal Transduction and Targeted Therapy Open access 17 Feb 2023 475
33 Bone marrow stromal/stem cell-derived extracellular vesicles regulate osteoblast activity and differentiation in vitro and promote bone regeneration in vivo Yunhao Qin, Lian Y. Wang, Zhengliang Gao et al. · Scientific Reports Open access 25 Feb 2016 467
34 Computational Approaches in Preclinical Studies on Drug Discovery and Development Fengxu Wu, Yuquan Zhou, Langhui Li et al. · Frontiers in Chemistry Open access 11 Sep 2020 441
35 FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease Ye Tian, Juan Lü, Xiaoqian Hao et al. · Neurotherapeutics Open access 21 Sep 2020 440
36 Long non-coding RNA: a new player in cancer Hua Zhang, Zhenhua Chen, Xinxin Wang et al. · Journal of Hematology & Oncology Open access 31 May 2013 439
37 Global variations in lung cancer incidence by histological subtype in 2020: a population-based study Yanting Zhang, Salvatore Vaccarella, Eileen Morgan et al. · The Lancet Oncology Open access 11 Oct 2023 436
38 Lessons on longevity from budding yeast Matt R. Kaeberlein · Nature Open access 23 Mar 2010 434
39 FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer Shucai Yang, Yi Liu, Mingyue Li et al. · Molecular Cancer Open access 17 Jul 2017 431
40 Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial Hai-Qiang Mai et al. · Nature Medicine 2 Aug 2021 417
41 Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11) Yunpeng Yang et al. · Journal of Thoracic Oncology Open access 8 Aug 2020 404
42 When Lamins Go Bad: Nuclear Structure and Disease Katherine H. Schreiber, Brian Keith Kennedy · Cell Open access Mar 2013 403
43 Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma Jian Huang, Qing Deng, Qun Wang et al. · Nature Genetics 26 Aug 2012 395
44 Meningeal lymphatic vessels regulate brain tumor drainage and immunity Xueting Hu et al. · Cell Research Open access 24 Feb 2020 391
45 Progeria syndromes and ageing: what is the connection? Christopher R. Burtner, Brian Keith Kennedy · Nature Reviews Molecular Cell Biology Review 23 Jul 2010 387
46 Genome Instability and Aging Jan Vijg, Yousin Suh · Annual Review of Physiology Review 10 Feb 2013 385
47 Secular trends in the prevalence of general and abdominal obesity among Chinese adults, 1993–2009 Bo Xi, Yajun Liang, Taiping He et al. · Obesity Reviews Open access 31 Oct 2011 383
48 Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer Shun Lü et al. · JAMA Open access 16 Jan 2024 380
49 IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy Caixia Yue, Peng Liu, Mingbin Zheng et al. · Biomaterials 15 Jun 2013 376
50 Machine learning for the prediction of acute kidney injury in patients with sepsis Suru Yue, Shasha Li, Xueying Huang et al. · Journal of Translational Medicine Open access 13 May 2022 374

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.